This week a new study was presented at an international medical conference in Texas and presented findings from multiple clinics that further strengthened the benefits about Pre-Implantation Genetic Screening (PGS) with Next Generational Sequencing (NGS). This is the first well designed study that gives robust evidence that PGS with NGS genetic screening is beneficial, and defines who it is beneficial for: 35-40 women and women with recurrent pregnancy loss. In this study, 50% reached ongoing pregnancy at 20 weeks versus 37% that did not use PGS / NGS technology. Repromed was the first in NZ to launch this new genetic screening technology (PGS with NGS) and is the first to offer this service locally in conjunction with Auckland University laboratory.
Medical Director Guy Gudex was talking with Mike Hosking about this exciting new research on Newstalk ZB this morning, listen here.
You can read the article from NZ Herald here.
If you’re interested in discussing if PGS genetic screening is right for you, Repromed offer a 15 minute phone consultation with a fertility doctor free of charge, call 0800 482 105 or email to book this in.
Individual results may vary dependant on your personal circumstances.